Science Daily: Pharmacology News
DECEMBER 3, 2024
An average of four minutes of incidental vigorous physical activity a day could almost halve the risk of major cardiovascular events, such as heart attacks, for middle-aged women who do not engage in structured exercise, according to new research.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
DECEMBER 3, 2024
Brain tissue is among the most energetically costly in the body, and as a result, larger-brained mammals require more energy to support brain growth and maintenance. Exactly which biological changes allowed human ancestors to meet the very high needs for energy as they evolved larger brains has remained unclear. A new study points to the role of gut microbes, tiny living organisms in our digestive system that help break down food and produce energy.
BioPharma Drive: Drug Pricing
DECEMBER 3, 2024
While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to differentiated results, some analysts said.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
DECEMBER 3, 2024
An unusual planetary system with three known ultra-low density 'super-puff' planets has at least one more planet, according to new observations.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
DECEMBER 3, 2024
Scientists demonstrate how a series of extreme weather events could lead to the Arctic's first ice-free day within just a few years.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a tough sell, too. Now, researchers at the Massachusetts Institute.
Nvidia Developer: Drug Discovery
DECEMBER 3, 2024
Antibodies have become the most prevalent class of therapeutics, primarily due to their ability to target specific antigens, enabling them to treat a wide range. Antibodies have become the most prevalent class of therapeutics, primarily due to their ability to target specific antigens, enabling them to treat a wide range of diseases, from cancer to autoimmune disorders.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- In 2006, Wolfgang Jäger was in his 30s when a skiing accident left the young Austrian wheelchair-bound from a spinal cord injury.Fast-forward to today, where an innovative deep-brain stimulation technique is helping the.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
DECEMBER 3, 2024
The process of obtaining a patent for a drug invention can be complex and time-consuming. Despite the best efforts of inventors and patent attorneys, many drug patent applications are rejected by patent offices. Understanding the common reasons for these rejections is crucial for overcoming them and securing patent protection for innovative pharmaceuticals.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- Folks soon might have their brain activity scanned using a temporary tattoo, a new study suggests.This temporary scalp tattoo allowed researchers to track electrical brain activity much more easily than with conventional.
BioPharma Drive: Drug Pricing
DECEMBER 3, 2024
The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to $558 million.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- Blocking blood flow to the site of knee arthritis can reduce pain and potentially prevent the need for knee replacement surgery, a new study says.The procedure, called genicular artery embolization (GAE), improved patients’.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
DECEMBER 3, 2024
A change in ownership and what it means for our readers.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- Maintaining muscle might be one way to help prevent dementia, new research suggests.“We found that older adults with smaller skeletal muscles are about 60% more likely to develop dementia when adjusted for other known risk f.
ACTO
DECEMBER 3, 2024
Now that the jet lag has faded, Ive been reflecting on my experiences from the recent Veeva Commercial Summit in Madrid. Kidding aside, it was more than a chance to network with pharma and biotech industry leaders; it was an opportunity to reinforce ACTO’s mission and our vision for the future of Life Sciences in Europe. As we broaden our global presence, the insights and connections made at the Summit will play a pivotal role in shaping our strategy and influence in this market.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- The hectic holidays play havoc on people’s nerves, not the least because they aren’t able to have any time to themselves.Nearly half (46%) of Americans say they don’t get the alone time they need during the holidays, accor.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
DECEMBER 3, 2024
Previous research found that insects can ingest and absorb pure, unrefined microplastics -- but only under unrealistic, food-scarce situations. Zoologists have now tested mealworms in a more realistic scenario, feeding them ground-up face masks -- a common plastic product -- mixed with bran, a tastier option. After 30 days, the research team found the mealworms ate about half the microplastics available, about 150 particles per insect, and gained weight.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- Pop music legend Elton John says that he can no longer see following an eye infection he battled last summer.The prolific singer-songwriter made the announcement Sunday at a charity gala performance of "The Devil Wears.
Covalent Modifiers
DECEMBER 3, 2024
Scott B. Ficarro, Zachary H. Marto, Nicholas M. Girardi, Dingyu Deng, Isabella Jaen Maisonet, Guillaume Adelmant, Laura E. Fleming, Mona Sharafi, Isidoro Tavares, Andrew Zhao, HyoJeon Kim, Hyuk-Soo Seo, Sirano Dhe-Paganon, Sara J. Buhrlage, Jarrod A. Marto SLAS Discovery, 2024 [link] Target-based screening of covalent fragment libraries with mass spectrometry has emerged as a powerful strategy to identify chemical starting points for small molecule inhibitors or find new binding pockets on prote
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Perficient: Drug Development
DECEMBER 3, 2024
How to Easily Manage and Display Data in Vue.js? Are you building a dynamic, interactive Vue.js app and wondering how to manage and display data efficiently? In this guide, we’ll show you how to easily store data, display it instantly on your page with Vue’s interpolation, and optimize complex calculations with computed properties. These features will help your app run faster and smoother than ever!
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- An accumulation of fat lurking around the organs of obese people is strongly linked to a buildup of Alzheimer's-linked proteins in the brain, new research finds.Buildup of this visceral fat in middle age may boost levels of.
addgene Blog
DECEMBER 3, 2024
Injections in mice are a day-to-day task for many labs. Deciding which type of injection to use depends on a number of factors. You have to weigh the pros and cons of various methods and choose what is best for you — and the mice. While not an exhaustive list, these can include what’s being injected, the type of experiment, the number of mice, the potential pain or discomfort of the mice, and restraint method.
Drugs.com
DECEMBER 3, 2024
TUESDAY, Dec. 3, 2024 -- A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell.
NIOSH Science Blog: Drugs
DECEMBER 3, 2024
While logging is still considered a high-risk industry, the mechanization of work has contributed to critical safety improvements. When at one time most loggers performed manual felling, today a logger’s workday is increasingly spent seated while operating heavy equipment. There is no doubt that mechanization has changed the industry in many ways. Researchers at the Northeast Center for Occupational Safety and Health in Agriculture, Forestry, and Fishing (Northeast Center), one of twelve funded
Expert insights. Personalized for you.
304 
Let's personalize your content